Product NDC: | 51672-4045 |
Proprietary Name: | Enalapril Maleate and Hydrochlorothiazide |
Non Proprietary Name: | Enalapril Maleate and Hydrochlorothiazide |
Active Ingredient(s): | 5; 12.5 mg/1; mg/1 & nbsp; Enalapril Maleate and Hydrochlorothiazide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4045 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075788 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010918 |
Package NDC: | 51672-4045-3 |
Package Description: | 1000 TABLET in 1 BOTTLE (51672-4045-3) |
NDC Code | 51672-4045-3 |
Proprietary Name | Enalapril Maleate and Hydrochlorothiazide |
Package Description | 1000 TABLET in 1 BOTTLE (51672-4045-3) |
Product NDC | 51672-4045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Enalapril Maleate and Hydrochlorothiazide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20010918 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE |
Strength Number | 5; 12.5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |